Case Report: Case studies evaluating anti-HER2 therapy as a tumor-agnostic strategy in rare malignancies - Quiz - MDSpire

Case Report: Case studies evaluating anti-HER2 therapy as a tumor-agnostic strategy in rare malignancies

  • By

  • Piyanoot Jitthiang

  • Rattanavit Phandthong

  • Ployploen Phikulsod

  • Siwanon Jirawatnotai

  • Narongsak Kiatikajornthada

  • Harit Suwanrusme

  • April 30, 2026

  • 0 min

Share

Original Source(s)

Case Report: Case studies evaluating anti-HER2 therapy as a tumor-agnostic strategy in rare malignancies

  • by Piyanoot Jitthiang, Rattanavit Phandthong, Ployploen Phikulsod, Siwanon Jirawatnotai, Narongsak Kiatikajornthada, Harit Suwanrusme

  • April 30, 2026

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential